OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits
Sara G. Higarza, Silvia Arboleya, Miguel Gueimonde, et al.
PLoS ONE (2019) Vol. 14, Iss. 9, pp. e0223019-e0223019
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
Natalia G. Vallianou, Gerasimos Socrates Christodoulatos, Ιrene Karampela, et al.
Biomolecules (2021) Vol. 12, Iss. 1, pp. 56-56
Open Access | Times Cited: 182

Role of gut microbiota via the gut-liver-brain axis in digestive diseases
Jianhong Ding, Zhe Jin, Xiaoxu Yang, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 40, pp. 6141-6162
Open Access | Times Cited: 122

Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease—Current Knowledge, Mechanisms and Perspectives
Kristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Charlotte Wilhelmina Wernberg, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 673-673
Open Access | Times Cited: 79

Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH
Martina Colognesi, Daniela Gabbia, Sara De Martin
Biomedicines (2020) Vol. 8, Iss. 7, pp. 229-229
Open Access | Times Cited: 78

Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats
Sara G. Higarza, Silvia Arboleya, Jorge L. Arias, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 74

S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent
Rosa M. Pascale, Maria M. Simile, Diego F. Calvisi, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 409-409
Open Access | Times Cited: 48

Elevated C-reactive protein mediates the liver-brain axis: a preliminary study
Rongtao Jiang, Jing Wu, Matthew Rosenblatt, et al.
EBioMedicine (2023) Vol. 93, pp. 104679-104679
Open Access | Times Cited: 20

Fecal microbiota profile in a group of myasthenia gravis patients
Germán Morís, Silvia Arboleya, Leonardo Mancabelli, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 55

Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease
Martin Marônek, René Link, Ľuboš Ambro, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 1013-1013
Open Access | Times Cited: 47

The inflammatory injury of heart caused by ammonia is realized by oxidative stress and abnormal energy metabolism activating inflammatory pathway
Huan Wang, Yu Zhang, Qi Han, et al.
The Science of The Total Environment (2020) Vol. 742, pp. 140532-140532
Closed Access | Times Cited: 41

Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study
Shanshan Wu, Changzheng Yuan, Zhirong Yang, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 27

MAFLD progression contributes to altered thalamus metabolism and brain structure
Saverio Nucera, Stefano Ruga, Antonio Cardamone, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24

A narrative review about cognitive impairment in Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD): Another matter to face through a holistic approach
Marica Meroni, Miriam Longo, Erika Paolini, et al.
Journal of Advanced Research (2024) Vol. 68, pp. 231-240
Open Access | Times Cited: 5

Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
Qi Zhang, Wenmin Xing, Qiao Wang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 21

Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21

Regulation of gut microbiome by ketogenic diet in neurodegenerative diseases: A molecular crosstalk
Shobana Kaviyarasan, Edmund Lee Chung Sia, Thaarvena Retinasamy, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 19

Impact of nonalcoholic fatty liver disease-related metabolic state on depression
Smaragda Ntona, Apostolis Papaefthymiou, Jannis Kountouras, et al.
Neurochemistry International (2023) Vol. 163, pp. 105484-105484
Closed Access | Times Cited: 12

Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Wesam Bahitham, S. Al-Ghamdi, Ibrahim Omer, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 550-550
Open Access | Times Cited: 4

The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review
Mauro Giuffrè, Nicola Merli, Maura Pugliatti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3337-3337
Open Access | Times Cited: 4

Research progress of the intestinal axis in autologous arteriovenous fistula stenosis in maintenance hemodialysis patients
Xuyang Luo, Wei Yang, Yuwei Kang, et al.
The Journal of Vascular Access (2025)
Closed Access

Ammonia exposure causes the imbalance of the gut-brain axis by altering gene networks associated with oxidative metabolism, inflammation and apoptosis
Yutao Li, Lei Pan, Xiangyin Zeng, et al.
Ecotoxicology and Environmental Safety (2021) Vol. 224, pp. 112668-112668
Open Access | Times Cited: 27

Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats
Maha Nasr, Omar A. Ahmed‐Farid, Rania F. Ahmed
Metabolic Brain Disease (2023) Vol. 38, Iss. 4, pp. 1365-1377
Open Access | Times Cited: 8

Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease
Qi Shao, Yiping Wu, Jing Ji, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 20

Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
Eleni Rebelos, Patricia Iozzo, Maria Angela Guzzardi, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 30, pp. 4999-5018
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top